You are here

  • Home
  • Archive
  • Volume 10, Issue 6
  • Increase in serum choline levels predicts for improved progression-free survival (PFS) in patients with advanced cancers receiving pembrolizumab

Article metrics

Article menu
Immunotherapy biomarkers
Original research
Increase in serum choline levels predicts for improved progression-free survival (PFS) in patients with advanced cancers receiving pembrolizumab

 

Online download statistics by month:

Online download statistics by month: June 2022 to July 2025

AbstractFullPdf
Jun 2022629643232
Jul 2022334336110
Aug 202221822272
Sep 202217718050
Oct 202219219443
Nov 202213813942
Dec 202211511625
Jan 202311311732
Feb 202310310544
Mar 202312312536
Apr 20239910022
May 2023646725
Jun 2023626425
Jul 2023545426
Aug 2023646522
Sep 2023505029
Oct 2023525626
Nov 2023707034
Dec 2023656533
Jan 2024545535
Feb 2024686927
Mar 2024797942
Apr 2024737550
May 202420720828
Jun 2024777648
Jul 2024787942
Aug 2024545330
Sep 2024707245
Oct 2024828237
Nov 2024717263
Dec 2024919241
Jan 202510610745
Feb 202512712758
Mar 2025606149
Apr 2025929267
May 2025676879
Jun 2025505136
Jul 2025220
Total423042881750